Eğitim Bilgileri
1991 - 1997
Doktora, İSTANBUL ÜNİVERSİTESİ, Cerrahpaşa tıp fakültesi
1998 - 2003
Tıpta Uzmanlık, Bezmialem Valide Sultan Eğitim ve Araştırma Hastanesi, İç hastalıkları
2016
Fitoterapi Sertifikası, Bezmialem Vakıf Üniversitesi
2016 - Halen...
Başhekim Yardımcısı, BEZMİÂLEM VAKIF ÜNİVERSİTESİ
Eserler ve Yayın Listesi
SCI,SSCI,AHCI İNDEKSLERİNE GİREN DERGİLERDE YAYINLANAN MAKALELER
- Zorlu M., Kiskac M., Çakirca M., Karatoprak C., Güler E., Celik K., et al., “Evaluation of the Relation between Vitamin D and Serum Omentin and Vaspin Levels in Women.”, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.124, pp.440-3, 2016Cikrikcioglu M., Sekin Y., Halac G., Kilic E., Kesgin S., Aydin S., et al., “Reduced bone resorption and increased bone mineral density in women with restless legs syndrome.”, NEUROLOGY, vol.86, pp.1235-41, 2016Cikrikcioglu M., Soytas R., Kilic E., Toprak A., Çakirca M., Zorlu M., et al., “CD40 ligand and P-selectin in heterozygous Beta-thalassemia.”, JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, vol.66, pp.699-704, 2016Zorlu M., Kiskaç M., Çakirca M., Karatoprak C. , Güler E.M., Celik K., et al.,”Evaluation of the Relation between Vitamin D and Serum Omentin and Vaspin Levels in Women”, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.124, pp.440-443, 2016 (Link)Cikrikcioglu M.A., Soytas R.B., Kilic E., Toprak A.E., Çakirca M., Zorlu M., et al., “CD40 ligand and p-selectin in heterozygous beta-thalassemia”, JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, vol.66, pp.699-704, 2016Celik K., Cikrikcioglu M., Halac G., Kilic E., Ayhan S., Ozaras N., et al., “Serum endocan levels in women with restless legs syndrome.”, NEUROPSYCHIATRIC DISEASE AND TREATMENT, vol.11, pp.2919-25, 2015Erkoc R., Cikrikcioglu M., Aintab E., Toprak A., Kilic U., Gok O., et al., “GAS6 intron 8 c.834 + 7G > A gene polymorphism in diabetic nephropathy.”, RENAL FAILURE, vol.37, pp.866-70, 2015Kiskac M., Zorlu M., Çakirca M., Büyükaydin B., Karatoprak C., Yavuz E., “Frequency and determinants of erectile dysfunction in Turkish diabetic men.”, NIGERIAN JOURNAL OF CLINICAL PRACTICE, vol.18, pp.209-12, 2015Çakirca M., Karatoprak C., Ugurlu S., Zorlu M., Kıskaç M., Çetin G., “Parvovirus B19 infection as a cause of acute myositis in an adult.”, REVISTA BRASILEIRA DE REUMATOLOGIA, vol.55, pp.185-8, 2015Karatoprak C., Kilicarslan R., Çakirca M., Aydin S., Ozkan T., Kocaman O., et al., “Effects of 18-Month Vildagliptin Treatment on Portal Vein Pressure”, DIABETES, vol.64, pp.A663-A663, 2015Kiskac M., Zorlu M., Akkoyunlu M., Kilic E., Karatoprak C., Çakirca M., et al., “Vaspin and lipocalin-2 levels in severe obsructive sleep apnea.”, JOURNAL OF THORACIC DISEASE, vol.6, pp.720-5, 2014Kiskac M., Zorlu M., Çakirca M., Karatoprak C., Kesgin S., Büyükaydin B., et al., “Evaluation of the relationship between serum apelin levels and vitamin D and mean platelet volume in diabetic patients.”, ANNALES D ENDOCRINOLOGIE, vol.75, pp.200-5, 2014Zorlu M., Kiskac M., Karatoprak C., Kesgin S., Çakirca M., Yildiz K., et al., “Assessment of serum apelin and lipocalin-2 levels in patients with subclinical hypothyroidism.”, ANNALES D ENDOCRINOLOGIE, vol.75, pp.10-4, 2014Çakirca M., Karatoprak C. , Zorlu M., Kiskaç M., Kanat M., Cikrikcioglu M.A., et al.,”Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients”, DRUG DESIGN DEVELOPMENT AND THERAPY, vol.8, pp.239-243, 2014Cikrikcioglu M., Karatoprak C., Çakirca M., Kiskac M., Zorlu M., Cetin G., et al., “Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease.”, EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.17, pp.2530-7, 2013Kiskac M., Zorlu M., Çakirca M., Karatoprak C., Peru C., Erkoc R., et al., “A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: a first report.”, INDIAN JOURNAL OF PHARMACOLOGY, vol.45, pp.305-6, 2013Karatoprak C., Yolbas S., Çakirca M., Cinar A., Zorlu M., Kiskac M., et al., “The effects of long term fasting in Ramadan on glucose regulation in type 2 diabetes mellitus.”, EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.17, pp.2512-6, 2013Zorlu M., Kiskac M., Karatoprak C., Çakirca M., Yavuz E., Cetin G., et al., “Pott’s disease and hypercalcemia in a patient with rheumatoid arthritis receiving methotrexate monotherapy.”, INDIAN JOURNAL OF PHARMACOLOGY, vol.45, pp.631-3, 2013Cikrikcioglu M.A., Karatoprak C., Çakirca M., Kiskac M., Zorlu M., Cetin G., et al., “Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease”, EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.17, pp.2530-2537, 2013Karatoprak C., Yolbas S., Çakirca M., Cinar A., Zorlu M., Kiskac M., et al., “The effects of long term fasting in Ramadan on glucose regulation in type 2 Diabetes Mellitus”, EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.17, pp.2512-2516, 2013Karatoprak C., Yolbas S., Kiskaç M., Zorlu M., Yay A., Çakirca M., et al., “The effects of short-acting analogue insulins on body weight in patients with type 2 diabetes mellitus”, TURKISH JOURNAL OF MEDICAL SCIENCES, vol.43, pp.268-272, 2013Cikrikcioglu M., Soysal P., Dikerdem D., Çakirca M., Kazancioglu R., Yolbas S., et al., “Absolute blood eosinophil count and 1-year mortality risk following hospitalization with acute heart failure.”, EUROPEAN JOURNAL OF EMERGENCY MEDICINE, vol.19, pp.257-63, 2012Hursitoglu M., Tukek T., Cikrikcioglu M., Kara O., Kazancioglu R., Ozkan O., et al., “Urotensin II levels in patients with chronic kidney disease and kidney transplants.”, UPSALA JOURNAL OF MEDICAL SCIENCES, vol.117, pp.22-7, 2012Uyanikoglu A., Akyuz F., Ermis F., Arici S., Bas G., Çakirca M., et al., “Does Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique.”, JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, vol.18, pp.187-93, 2012Cikrikcioglu M., Halac G., Hursitoglu M., Erkal H., Çakirca M., Kinas B., et al., “Prevalence of gluten sensitive enteropathy antibodies in restless legs syndrome.”, ACTA NEUROLOGICA BELGICA, vol.111, pp.282-6, 2011Cikrikcioglu M., Hursitoglu M., Erkal H., Kinas B., Sztajzel J., Çakirca M., et al., “Oxidative stress and autonomic nervous system functions in restless legs syndrome.”, EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, vol.41, pp.734-42, 2011Hursitoglu M., Tukek T., Cikrikcioglu M.A., Kara O., Kazancioğlu R., Ozkan O., et al., “UROTENSIN II LEVELS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND KIDNEY TRANSPLANTS”, TRANSPLANT INTERNATIONAL, vol.24, pp.289-289, 2011Cikrikcioglu M.A., Halac G., Hursitoglu M., Erkal H., Çakirca M., Kinas B.E., et al., “Prevalence of Gluten Sensitive Enteropathy antibodies in Restless Legs Syndrome”, ACTA NEUROLOGICA BELGICA, vol.111, pp.282-286, 2011Uyanikoglu A., Akyuz F., Bas G., Çakirca M., Baran B., Ermis F., et al., “Does Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique”, GASTROINTESTINAL ENDOSCOPY, vol.71, pp.AB268-AB268, 2010Cikrikcioglu M., Hursitoglu M., Erkal H., Inan B., Ozturk T., Çakirca M., et al., “Splenomegaly in primary antiphospholipid syndrome without accompanying portal hypertension or comorbidity.”, PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, vol.37, pp.104-9, 2010Hursitoglu M., Çakirca M., Cikrikcioglu M.A., Tukek T., “The interferon-gamma-based QuantiFERON®-TB Gold In-Tube test and the type of haemodialysis process”, SWISS MEDICAL WEEKLY, vol.140, pp.388-388, 2010Hursitoglu M., Çakirca M., Cikrikcioglu M.A., Tukek T., “The interferon-gamma-based QuantiFERON (R)-TB Gold In-Tube test and the type of haemodialysis process”, SWISS MEDICAL WEEKLY, vol.140, pp.388-388, 2010Cikrikcioglu M.A., Elik I., Hursitoglu M., Erkal H., Çakirca M., Kurt T., et al., “The Prevalence of Low T3 With Arrhythmia and Heart Failure in Patients With Acute Coronary Syndrome”, ENDOCRINOLOGIST, vol.20, pp.23-26, 2010Uyanikoglu A., Davudoglu C., Çakirca M., Danalioglu A., “Is peptic ulcer incidence decreasing?”, NOBEL MEDICUS, vol.5, pp.15-17, 2009
DİĞER DERGİLERDE YAYINLANAN MAKALELER
- Karatoprak C., Kilicarslan R., Çakirca M., Aydin S., Ozkan T., Kocaman O., et al., “Vildagliptin Treatment on the Portal Venous Pressure and Hepatosteatosis in Patients with Type 2 Diabetes Mellitus”, BEZMIALEM SCIENCE, vol.6, pp.1-5, 2018Karatoprak C., Arabaci E., Yildiz K., Çakirca M., Cikrikcioglu M., Ergun F., et al., “Gastroenterology cases of cutaneous leukocytoclastic vasculitis.”, Case reports in medicine, vol.2013, pp.264189-264189, 2013
HAKEMLİ KONGRE / SEMPOZYUMLARIN BİLDİRİ KİTAPLARINDA YER ALAN YAYINLAR
- Çakirca M., “”, , TURKİYE,Karatoprak C., Batar N., Zorlu M., Çakirca M., Kiskaç M., “obezlerde tempolu yürüyüş sıklığı ile metabolik parametreler arasındaki ilişki”, 19.ulusal iç hastalıkları kongresi, TÜRKIYE,
KİTAP ve KİTAP BÖLÜMLERİ
Çakirca M., “Urinary incontinance”, in: New Horizons in Geriatric Medicine, Işık A.T., Mas R., Karan M.A.,, . Grossberg G.T., Eds., Nova Biomedical, Sience Publishers, Newyork, pp.3-14, 2013 (Link)
Prof. Dr. Mustafa ÇAKIRCA'ya Soru Sor..
Şeker Hastalığı, Metabolik Sendrom, Yüksek Tansiyon, Kolesterol, Trigliserid, Aşıeı Şişmanlık, Kan Hastalıkları, Tiroid Bezi Hastalıkları, Mide, Bağırsak Hastalıkları, Bitkisel Tedavi ve daha bir çok konuda aklınıza takılan her şeyi Doç. Dr. Mustafa Çakırca’ya sorun….